Share on LinkedInShare on LinkedIn

ARTICLE · 15 DECEMBER 2017

New Patented Medicines Prices Review Board (PMPRB) Regulations Open For Comment

Gowling WLG
Gowling WLG
Contributor
Gowling WLG

Gowling WLG

The firm The firm’s lawyers speak English, French, Russian and Ukrainian. The firm’s client base...

View firm profile
Explore more from Gowling WLG

The Canadian government recently published its proposed Regulations Amending the Patented Medicines Regulations (the "Regulations") for coming into force January 1, 2019.

CanadaIntellectual Property

The Canadian government recently published its proposed Regulations Amending the Patented Medicines Regulations (the "Regulations") for coming into force January 1, 2019. The proposed Regulations are currently open for public consultation. The Office of Pharmaceuticals Management Strategies, Strategic Policy Branch, Health Canada will receive comments from interested persons until February 15, 2018.

The Regulations are pursuant to provisions of the Patent Act which are administered by the Patented Medicines Prices Review Board ("PMPRB") The PMPRB is best known for its mandate relating to its patented drug price reporting requirements and protecting consumers against excessive pricing of patented medicines. The proposed Regulations:

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from